Glassman Wealth Services’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-716
| Closed | -$338K | – | 700 |
|
|
2023
Q4 | $338K | Sell |
716
-6
| -0.8% | -$2.77K | 0.05% | 121 |
|
|
2023
Q3 | $314K | Sell |
722
-26
| -3% | -$11.8K | 0.05% | 115 |
|
|
2023
Q2 | $332K | Sell |
748
-34
| -4% | -$15.7K | 0.05% | 110 |
|
|
2023
Q1 | $360K | Buy |
782
+6
| +0.8% | +$2.85K | 0.06% | 100 |
|
|
2022
Q4 | $398K | Buy |
776
+7
| +0.9% | +$3.55K | 0.07% | 101 |
|
|
2022
Q3 | $349K | Buy |
769
+30
| +4% | +$14.4K | 0.07% | 92 |
|
|
2022
Q2 | $357K | Buy |
739
+40
| +6% | +$19.8K | 0.07% | 98 |
|
|
2022
Q1 | $343K | Sell |
699
-28
| -4% | -$12.8K | 0.06% | 110 |
|
|
2021
Q4 | $337K | Buy |
727
+254
| +54% | +$107K | 0.06% | 104 |
|
|
2021
Q3 | $176K | Buy |
473
+27
| +6% | +$10.3K | 0.04% | 168 |
|
|
2021
Q2 | $170K | Sell |
446
-66
| -13% | -$25.2K | 0.04% | 161 |
|
|
2021
Q1 | $184K | Buy |
512
+24
| +5% | +$7.72K | 0.04% | 148 |
|
|
2020
Q4 | $157K | Buy |
488
+31
| +7% | +$9.51K | 0.04% | 166 |
|
|
2020
Q3 | $123K | Buy |
457
+49
| +12% | +$13.2K | 0.03% | 174 |
|
|
2020
Q2 | $107K | Buy |
408
+39
| +11% | +$10.4K | 0.03% | 161 |
|
|
2020
Q1 | $84K | Sell |
369
-18
| -5% | -$4.91K | 0.03% | 178 |
|
|
2019
Q4 | $117K | Buy |
387
+85
| +28% | +$23.4K | 0.04% | 166 |
|
|
2019
Q3 | $73K | Sell |
302
-50
| -14% | -$13.7K | 0.03% | 195 |
|
|
2019
Q2 | $99K | Buy |
352
+89
| +34% | +$24.3K | 0.04% | 167 |
|
|
2019
Q1 | $75K | Buy |
263
+133
| +102% | +$38.5K | 0.03% | 193 |
|
|
2018
Q4 | $34K | Hold |
130
| – | – | 0.02% | 236 |
|
|
2018
Q3 | $36K | Hold |
130
| – | – | 0.02% | 246 |
|
|
2018
Q2 | $31K | Buy |
130
+3
| +2% | +$695 | 0.02% | 241 |
|
|
2018
Q1 | $28K | Sell |
127
-4
| -3% | -$940 | 0.02% | 237 |
|
|
2017
Q4 | $29K | Buy |
131
+12
| +10% | +$2.56K | 0.02% | 210 |
|
|
2017
Q3 | $23K | Hold |
119
| – | – | 0.02% | 219 |
|
|
2017
Q2 | $22K | Buy |
119
+100
| +526% | +$18K | 0.01% | 230 |
|
|
2017
Q1 | $3K | Hold |
19
| – | – | ﹤0.01% | 425 |
|
|
2016
Q4 | $3K | Buy |
19
+16
| +533% | +$2.14K | ﹤0.01% | 472 |
|
|
2016
Q3 | $0 | Buy |
+3
| New | +$387 | ﹤0.01% | 502 |
|
|
2015
Q1 | – | Sell |
-100
| Closed | -$13K | – | 435 |
|
|
2014
Q4 | $13K | Buy |
+100
| New | +$12.4K | 0.01% | 320 |
|
Other funds holding ELV
Glassman Wealth Services's ELV Position: Q1 2024 in Review
Glassman Wealth Services sold out of Elevance Health (ELV) in Q1 2024, closing a stake of 716 shares — an estimated $338K sold.
Glassman Wealth Services first reported a position in ELV in Q4 2014 and held it in 31 quarters. The position peaked at $398K in Q4 2022. 1,672 funds tracked by Wall St. Rank hold ELV as of Q1 2024.
- Glassman Wealth Services reported no remaining Elevance Health position as of Q1 2024 after selling out during the quarter.
- Glassman Wealth Services sold 716 Elevance Health shares in Q1 2024, an estimated $338K.
- Glassman Wealth Services first reported a position in Elevance Health in Q4 2014 and held it in 31 quarters.
- Glassman Wealth Services's Elevance Health position peaked at $398K in Q4 2022.
- 1,672 funds tracked by Wall St. Rank held Elevance Health as of Q1 2024.
Based on Glassman Wealth Services's 13F filing for Q1 2024, filed 3 May 2024.